Showing results (11-20 of 31) with videos related to

Sort By:
Pageof 4
Plos Pathogens|August 11, 2011
The cost of virulence: retarded growth of Salmonella Typhimurium cells expressing type III secretion system 1Alexander Sturm, Matthias Heinemann, Markus Arnoldini, et al.
American Journal of Physiology. Renal Physiology|June 15, 2007
Identification of cysteines in rat organic cation transporters rOCT1 (C322, C451) and rOCT2 (C451) critical for transport activity and substrate affinityAlexander Sturm, Valentin Gorboulev, Dmitry Gorbunov, et al.
Journal of Medical Microbiology|November 8, 2024
Nanomotion technology: an innovative method to study cell metabolism in Escherichia coli, as a potential indicator for toleranceChristèle Aubry, Carole Kebbi-Beghdadi, Amanda Luraschi-Eggemann, et al.
Palliative Medicine|October 30, 2019
'. . . and then no more kisses!' Exploring patients' experiences on multidrug-resistant bacterial microorganisms and hygiene measures in end-of-life care A mixed-methods studyMaria Heckel, Alexander Sturm, Stephanie Stiel, et al.
Journal of Clinical Nursing|May 6, 2018
Staff members' ambivalence on caring for patients with multidrug-resistant bacteria at their end of life: A qualitative studyJohanna M Tiedtke, Stephanie Stiel, Maria Heckel, et al.
Microbes and Infection|May 19, 2023
Nanomotion technology in combination with machine learning: a new approach for a rapid antibiotic susceptibility test for Mycobacterium tuberculosisAnthony Vocat, Alexander Sturm, Grzegorz Jóźwiak, et al.
Microbiology Spectrum|April 24, 2025
Nanomotion technology for testing azithromycin susceptibility of Salmonella entericaMariliis Hinnu, Toomas Mets, Ivana Kerkez, et al.
Microbiology Spectrum|June 30, 2026
Rapid delineation of Acinetobacter baumannii dose responses to zosurabalpin based on machine learning-assisted interpretation of bacterial nanomotionsMarta Pla Verge, Jan Winnicki, Amanda Luraschi-Eggemann, et al.
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer|March 18, 2018
Multidrug-resistant bacterial microorganisms (MDRO) in end-of-life care: development of recommendations for hospitalized patients using a mixed-methods approachMaria Heckel, Stephanie Stiel, Franziska A Herbst, et al.
BMJ Open|November 21, 2022
Investigating nanomotion-based technology (Resistell AST) for rapid antibiotic susceptibility testing among adult patients admitted to a tertiary-care hospital with Gram-negative bacteraemia: protocol for a prospective, observational, cross-sectional, single-arm studyGiorgia Caruana, Antonios Kritikos, Anthony Vocat, et al.
Pageof 4